Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.7378 | 1 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0045 | 0.2213 | 0.3307 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.1958 | 0.1747 |
Brugia malayi | jmjC domain containing protein | 0.0045 | 0.2213 | 0.1741 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.236 | 0.1897 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3921 | 0.5859 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3903 | 0.5833 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 1 | 1 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0035 | 0.1138 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.6692 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1796 | 0.1299 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.205 | 0.2778 |
Plasmodium falciparum | phd finger protein, putative | 0.0035 | 0.1138 | 0.5 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.2664 | 0.2472 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0.1138 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.5219 | 0.5094 |
Brugia malayi | Bromodomain containing protein | 0.0038 | 0.1455 | 0.0937 |
Echinococcus multilocularis | PHD finger protein rhinoceros | 0.0035 | 0.1138 | 0.0906 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0035 | 0.1138 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.205 | 0.1842 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0045 | 0.2213 | 0.2999 |
Brugia malayi | PHD-finger family protein | 0.0035 | 0.1138 | 0.0601 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2686 | 0.4014 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.237 | 0.3541 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.1138 | 0.1701 |
Echinococcus granulosus | PHD finger protein rhinoceros | 0.0035 | 0.1138 | 0.0906 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0045 | 0.2213 | 0.2009 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.2044 | 0.1835 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.5219 | 0.5094 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.205 | 0.1842 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1796 | 0.2434 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.7263 | 0.7097 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2941 | 0.4395 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.205 | 0.2778 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 1 | 1 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.5698 | 0.7722 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.1138 | 0.1543 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.205 | 0.5 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0035 | 0.1138 | 0.1701 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1796 | 0.2684 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0045 | 0.2213 | 0.2999 |
Onchocerca volvulus | Alhambra homolog | 0.0035 | 0.1138 | 0.5 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.2664 | 0.2472 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.3903 | 0.3534 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0255 | 0.0346 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.205 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.3903 | 0.5833 |
Giardia lamblia | PHD finger protein 15 | 0.0035 | 0.1138 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.205 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.3903 | 0.3534 |
Echinococcus granulosus | peregrin | 0.0038 | 0.1455 | 0.1231 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.5286 | 0.7899 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.205 | 0.5 |
Echinococcus multilocularis | peregrin | 0.0038 | 0.1455 | 0.1231 |
Schistosoma mansoni | bromodomain-containing nuclear protein 1 brd1 | 0.0035 | 0.1138 | 0.1543 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.2044 | 0.1835 |
Brugia malayi | hypothetical protein | 0.0043 | 0.205 | 0.1568 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.0795 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.3225 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 23.0999 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.